Background
Background An increased incidence An increased incidence of brain white-matter hyperintensities has of brain white-matter hyperintensities has been described in major depressive been described in major depressive disorder, but the impact of such disorder, butthe impact of such hyperintensities on treatment outcome is hyperintensities on treatment outcome is still controversial. still controversial.
Aims Aims To investigate the relationship of
To investigate the relationship of brain white-matter hyperintensities with brain white-matter hyperintensities with cardiovascular risk factors and with cardiovascular risk factors and with treatment outcome in younger people treatment outcome in younger people with major depressive disorder. with major depressive disorder.
Method Method We assessed brain white-
We assessed brain whitematter hyperintensities and cardiovascular matter hyperintensities and cardiovascular risk factors in 84 people with major risk factors in 84 people with major depressive disorder prior to initiating depressive disorder prior to initiating antidepressanttreatment.We also antidepressanttreatment.We also assessed hyperintensities in 35 matched assessed hyperintensities in 35 matched controls. controls.
Results

Results We found no significant
We found no significant difference in the prevalence of whitedifference in the prevalence of whitematter hyperintensities between the matter hyperintensities between the depression and the control groups.Leftdepression and the control groups.Lefthemisphere subcortical hyperintensities hemisphere subcortical hyperintensities correlated with lower rates of treatment correlated with lower rates of treatment response.We found no correlation response.We found no correlation between global hyperintensity measures between global hyperintensity measures and clinical outcome.Brain white-matter and clinical outcome.Brain white-matter hyperintensities correlated with hyperintensities correlated with hypertension and age and with total hypertension and age and with total cardiovascular risk score. cardiovascular risk score.
Conclusions Conclusions Subcortical white-matter
Subcortical white-matter hyperintensitiesintheleft hemisphere (but hyperintensitiesintheleft hemisphere (but notin other brain areas) may be associated notin other brain areas) may be associated with poor response to antidepressant with poor response to antidepressant treatment in major depression. treatment in major depression.
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The association between major depressive The association between major depressive disorder and increased prevalence of brain disorder and increased prevalence of brain white-matter hyperintensities has been rewhite-matter hyperintensities has been reported in elderly people (Krishnan ported in elderly people (Krishnan et al et al, , 1997; de Groot 1997; de Groot et al et al, 2000) , but studies in , 2000), but studies in younger patients have been inconclusive younger patients have been inconclusive (Coffey (Coffey et al et al, 1993; Lenze , 1993; Lenze et al et al, 1999; Lyoo , 1999; Lyoo et al et al, 2002) . In samples of elderly people , 2002) . In samples of elderly people with depression, such hyperintensities were with depression, such hyperintensities were associated with lower rates of response to associated with lower rates of response to antidepressant treatment (Hickie antidepressant treatment (Hickie et al et al, , 1997; Simpson 1997; Simpson et al et al, 1998; Steffens , 1998; Steffens et al et al, , 2002) as well as higher rates of relapse dur-2002) as well as higher rates of relapse during follow-up (O'Brien ing follow-up (O'Brien et al et al, 1998; Yanai , 1998; Yanai et et al al, 1998) . The study reported here is, to our , 1998). The study reported here is, to our knowledge, the first to explore the impact knowledge, the first to explore the impact of white-matter hyperintensities on antiof white-matter hyperintensities on antidepressant treatment outcome and the depressant treatment outcome and the relationship between such hyperintensities relationship between such hyperintensities and cardiovascular risk factors in younger and cardiovascular risk factors in younger people with depression. We predicted that people with depression. We predicted that the presence of brain white-matter hyperthe presence of brain white-matter hyperintensities would correlate with cardiovasintensities would correlate with cardiovascular risk factors and with lower rates of cular risk factors and with lower rates of treatment response. treatment response.
METHOD METHOD Participants Participants
All study participants signed consent forms, All study participants signed consent forms, approved by the institutional review board, approved by the institutional review board, prior to the initial study visit. prior to the initial study visit.
Non-treatment-resistant major depressive Non-treatment-resistant major depressive disorder disorder
The study group with non-treatmentThe study group with non-treatmentresistant major depressive disorder comresistant major depressive disorder comprised 65 people aged (Nierenberg et al et al, 2003) . Patients , 2003) . Patients eligible for inclusion were men and women eligible for inclusion were men and women aged 18-70 years with major depressive aged 18-70 years with major depressive disorder diagnosed using the SCID-P and disorder diagnosed using the SCID-P and a score on the HRSD of at least 18. a score on the HRSD of at least 18. Treatment resistance was defined as nonTreatment resistance was defined as nonresponse to at least one, but no more than response to at least one, but no more than five, adequate antidepressant trials during five, adequate antidepressant trials during the current depressive episode. the current depressive episode.
Exclusion criteria Exclusion criteria
For both the depressive disorder samples, For both the depressive disorder samples, exclusion criteria were bipolar disorder, exclusion criteria were bipolar disorder, psychotic disorder, a history of organic psychotic disorder, a history of organic mental or seizure disorder, serious or unmental or seizure disorder, serious or unstable medical illness, substance misuse or stable medical illness, substance misuse or dependence disorder active within the past dependence disorder active within the past 12 months, acute suicidal risk, pregnancy, 12 months, acute suicidal risk, pregnancy, lactation, history of adverse reaction or allactation, history of adverse reaction or allergy to the study medications, concomitant lergy to the study medications, concomitant use of psychotropic medications, clinical or use of psychotropic medications, clinical or laboratory evidence of thyroid abnormallaboratory evidence of thyroid abnormalities, an existing diagnosis of dementia or ities, an existing diagnosis of dementia or a score below 27 on the Mini-Mental State a score below 27 on the Mini-Mental State Examination (Folstein Examination (Folstein et al et al, 1975), and any , 1975) , and any contraindication to magnetic resonance contraindication to magnetic resonance imaging, including metallic implants or imaging, including metallic implants or severe claustrophobia. severe claustrophobia.
Controls Controls
We also recruited through advertisements We also recruited through advertisements 35 healthy volunteers, matched for age 35 healthy volunteers, matched for age and gender (40% females; mean age 39.3 and gender (40% females; mean age 39.3 years, s.d. years, s.d.¼9.8). These volunteers under-9.8). These volunteers underwent the physician-administered SCID-P went the physician-administered SCID-P to rule out any Axis I psychopathology. to rule out any Axis I psychopathology.
Tests and procedures Tests and procedures
We assessed cardiovascular risk factors in We assessed cardiovascular risk factors in all participants with major depressive disall participants with major depressive disorder following the After the initial evaluation the nonAfter the initial evaluation the nontreatment-resistant sample entered 8 weeks treatment-resistant sample entered 8 weeks of open-label treatment with fluoxetine of open-label treatment with fluoxetine 20 mg daily, following a 1-week wash-out 20 mg daily, following a 1-week wash-out phase. The HRSD was administered at each phase. The HRSD was administered at each study visit (screen, baseline and then every study visit (screen, baseline and then every other week for 8 weeks). The treatmentother week for 8 weeks). The treatmentresistant group were prescribed nortriptyresistant group were prescribed nortriptyline at an initial dosage of 25 mg, which line at an initial dosage of 25 mg, which was increased by 25 mg per day until a was increased by 25 mg per day until a dosage of 100 mg was reached, unless dosage of 100 mg was reached, unless patients were unable to tolerate the dosage patients were unable to tolerate the dosage increase because of side-effects. Blood increase because of side-effects. Blood levels of nortriptyline were measured at levels of nortriptyline were measured at weeks 2 and 6, and dosage adjustments weeks 2 and 6, and dosage adjustments were made after the second week if blood were made after the second week if blood levels were below 400 nmol/l. Participants levels were below 400 nmol/l. Participants then maintained their dosage of nortriptythen maintained their dosage of nortriptyline for 6 weeks. The HRSD was adminisline for 6 weeks. The HRSD was administered at each study visit (screen, baseline tered at each study visit (screen, baseline and then weekly for 6 weeks). and then weekly for 6 weeks).
Brain imaging procedures Brain imaging procedures
All participants underwent brain magnetic All participants underwent brain magnetic resonance imaging using a 1.5 T (Signa, resonance imaging using a 1.5 T (Signa, General Electric, Milwaukee, Wisconsin, General Electric, Milwaukee, Wisconsin, USA) whole-body imaging device. We ob-USA) whole-body imaging device. We obtained axial proton-density images, tained axial proton-density images, T T 3.0 mm. Analysis of the images was performed offAnalysis of the images was performed offline using a SUN Microsystems (Mountainline using a SUN Microsystems (Mountainview, California, USA) Sparc2 workstation view, California, USA) Sparc2 workstation and the radiological film. Lesions were clasand the radiological film. Lesions were classified according to the Fazekas classification sified according to the Fazekas classification system (Fazekas system (Fazekas et al et al, 1987) , which pro-, 1987), which provides an assessment of severity of the vides an assessment of severity of the white-matter hyperintensities, rated sepawhite-matter hyperintensities, rated separately for the subcortical white matter rately for the subcortical white matter (range 0-3) and the periventricular white (range 0-3) and the periventricular white matter (range 0-3). The total white-matter matter (range 0-3). The total white-matter hyperintensity score was considered to be hyperintensity score was considered to be the higher of the subcortical score and the the higher of the subcortical score and the periventricular score, following previous periventricular score, following previous classifications of white-matter hyperintenclassifications of white-matter hyperintensity in people with major depressive dissity in people with major depressive disorder (Krishnan order (Krishnan et al et al, 1997) . All ratings of , 1997). All ratings of white-matter hyperintensities were done by white-matter hyperintensities were done by an experienced neuroradiologist (H.K.L.), an experienced neuroradiologist (H.K.L.), who was unaware of participant identity who was unaware of participant identity and clinical status. Another investigator in and clinical status. Another investigator in the study (D.V.I.) assessed independently a the study (D.V.I.) assessed independently a selection of 111 magnetic resonance images selection of 111 magnetic resonance images using the same rating criteria, for measureusing the same rating criteria, for measurement of interrater reliability. This was very ment of interrater reliability. This was very good: the number of observed agreements good: the number of observed agreements was 98 (88.3%) and weighted was 98 (88.3%) and weighted k k¼0.82. 0.82. The presence of severe hyperintensities The presence of severe hyperintensities was defined as a Fazekas scale score of 2 was defined as a Fazekas scale score of 2 or over, whereas scores below 2 were cateor over, whereas scores below 2 were categorised as not severe, following previous gorised as not severe, following previous classifications in people with major classifications in people with major depressive disorder (Krishnan depressive disorder (Krishnan et al et al, 1997) . , 1997). In addition to the Fazekas scale scores, we In addition to the Fazekas scale scores, we determined the localisation of hyperdetermined the localisation of hyperintensities by hemisphere (left or right). intensities by hemisphere (left or right). Subcortical hyperintensities were also Subcortical hyperintensities were also localised as being in the frontal lobe or localised as being in the frontal lobe or not in the frontal lobe area, using the not in the frontal lobe area, using the central sulcus as a boundary. central sulcus as a boundary.
Data analyses Data analyses
The clinical outcome variables were reThe clinical outcome variables were response (reduction in HRSD score of 50% sponse (reduction in HRSD score of 50% or more) and remission (final HRSD score or more) and remission (final HRSD score of 7 or less). We analysed the clinical data of 7 or less). We analysed the clinical data using the last observation carried forward using the last observation carried forward method. Group differences in demographic method. Group differences in demographic and clinical variables involving continuous and clinical variables involving continuous data were computed using analysis of data were computed using analysis of variance (ANOVA) (age) or unpaired variance (ANOVA) (age) or unpaired t t-tests -tests (HRSD scores, percentage change in HRSD (HRSD scores, percentage change in HRSD scores). scores).
The differences in the severity of whiteThe differences in the severity of whitematter hyperintensities between particimatter hyperintensities between participants in the two depression groups and pants in the two depression groups and the healthy comparison sample were anathe healthy comparison sample were analysed using lysed using w w 2 2 -tests. We used multiple ordi--tests. We used multiple ordinal logistic regression to test the association nal logistic regression to test the association between hyperintensity scores and cardiobetween hyperintensity scores and cardiovascular risk factors. Analysis of variance vascular risk factors. Analysis of variance was used to test the association between was used to test the association between hyperintensity scores and the total cardiohyperintensity scores and the total cardiovascular risk score (sum of the six vascular risk score (sum of the six cardiovascular risk factors). Since age is cardiovascular risk factors). Since age is one of the cardiovascular risk factors, these one of the cardiovascular risk factors, these analyses were not adjusted for age. Correlaanalyses were not adjusted for age. Correlations between clinical outcome variables tions between clinical outcome variables (response and remission) and hyper-(response and remission) and hyperintensity scores were tested using logistic intensity scores were tested using logistic regression, adjusted for age. Statistical regression, adjusted for age. Statistical significance was defined as significance was defined as P P5 50.05, 0.05, two-tailed. two-tailed.
RESULTS RESULTS
The demographic and clinical characterisThe demographic and clinical characteristics of the three study groups are presented tics of the three study groups are presented in The incidence of total brain whiteThe incidence of total brain whitematter hyperintensities in the group with matter hyperintensities in the group with non-treatment-resistant depressive disorder non-treatment-resistant depressive disorder (63%) was not statistically different from (63%) was not statistically different from that of the treatment-resistant group that of the treatment-resistant group (53%) or the control group (60%); (53%) or the control group (60%); w w 2 2 ¼0.881, 0.881, P P¼0.83. Also, the incidence of 0.83. Also, the incidence of severe brain hyperintensities in the nonsevere brain hyperintensities in the nontreatment-resistant group (8%) was not treatment-resistant group (8%) was not statistically different from that of the statistically different from that of the treatment-resistant group (5%) or the contreatment-resistant group (5%) or the control group (6%); trol group (6%); w w 2 2 ¼0.364, 0.364, P P¼0.95. As ex-0.95. As expected, the individual's age correlated with pected, the individual's age correlated with the severity of brain hyperintensities the severity of brain hyperintensities (ANOVA, d.f. (ANOVA, d.f.¼117, 117, F F¼11.0, 11.0, P P¼0.0012). 0.0012). In all three study groups the majority of In all three study groups the majority of subcortical hyperintensities were localised subcortical hyperintensities were localised in the frontal lobe area: 87% of lesions in in the frontal lobe area: 87% of lesions in the treatment-resistant group were in the the treatment-resistant group were in the frontal lobe, 79% of lesions in the nonfrontal lobe, 79% of lesions in the nontreatment-resistant group and 100% in treatment-resistant group and 100% in the control group, with no statistically the control group, with no statistically significant difference between groups significant difference between groups ( (w w White-matter hyperintensities White-matter hyperintensities and treatment outcome and treatment outcome
After adjusting for age there was no statisAfter adjusting for age there was no statistically significant relationship between the tically significant relationship between the total hyperintensity severity score and the total hyperintensity severity score and the clinical outcome measures of response to clinical outcome measures of response to treatment and remission (Table 2) . Howtreatment and remission ( 10.4, 95% CI 0.8-135.1). Of note, there was no significant difference in the there was no significant difference in the incidence of subcortical hyperintensities in incidence of subcortical hyperintensities in the left hemisphere between the treatmentthe left hemisphere between the treatmentresistant and the non-treatment-resistant resistant and the non-treatment-resistant depression groups (26% depression groups (26% v.
v. 23%; 23%; P P4 40.05). 0.05). After adjusting for age there was no statisAfter adjusting for age there was no statistically significant relationship between peritically significant relationship between periventricular white-matter hyperintensities and ventricular white-matter hyperintensities and response to treatment or remission (Table 2 ). response to treatment or remission (Table 2) .
Correlation between white-matter Correlation between white-matter hyperintensities and cardiovascular hyperintensities and cardiovascular risk factors risk factors
The white-matter hyperintensity score The white-matter hyperintensity score was significantly correlated with the was significantly correlated with the cardiovascular risk score ( cardiovascular risk score (P P¼0.037; Table  0.037; Table  3 ). In a multiple ordinal logistic regression 3). In a multiple ordinal logistic regression analysis examining individual cardiovascular analysis examining individual cardiovascular 1 8 2 1 8 2 AUTHOR'S PROOF AUTHOR'S PROOF 
Any PWHM (PWHM Any PWHM (PWHM5 51) 1) 6 (32) 6 (32) 29 (45) 29 (45) 15 (43) 15 (43) Severe PWMH (PWMH Severe PWMH (PWMH5 52) 2)
Deep ( 
F F P P
Coef. Coef.
Coef. Coef. risk factors as predictors, greater total brain risk factors as predictors, greater total brain white-matter hyperintensity score was white-matter hyperintensity score was associated with age ( associated with age (P P¼0.016) and with 0.016) and with hypertension ( hypertension (P P¼0.001). Two other 0.001). Two other cardiovascular risk factors did not reach cardiovascular risk factors did not reach statistical significance in relation to total statistical significance in relation to total hyperintensity score: cholesterol level hyperintensity score: cholesterol level ( (P P¼0.053) and family history of cardiovas-0.053) and family history of cardiovascular disease ( cular disease (P P¼0.098). The presence of 0.098). The presence of diabetes and smoking status were not corrediabetes and smoking status were not correlated with the total hyperintensity score. lated with the total hyperintensity score. The presence of severe hyperintensities also The presence of severe hyperintensities also correlated with age ( correlated with age (P P¼0.012) and with 0.012) and with hypertension ( hypertension (P P¼0.041), as well as with 0.041), as well as with the total cardiovascular risk score the total cardiovascular risk score ( (P P¼0.011). 0.011).
The total cardiovascular risk score was The total cardiovascular risk score was correlated with the severity of periventricucorrelated with the severity of periventricular hyperintensities ( lar hyperintensities (P P¼0.008) and of sub-0.008) and of subcortical hyperintensities ( cortical hyperintensities (P P¼0.047). In a 0.047). In a multiple logistic regression, the severity of multiple logistic regression, the severity of periventricular hyperintensity correlated periventricular hyperintensity correlated with age ( with age (P P¼0.023) and hypercholestero-0.023) and hypercholesterolaemia ( laemia (P P¼0.017), whereas hypertension 0.017), whereas hypertension did not reach statistical significance did not reach statistical significance ( (P P¼0.088). Hypertension also did not reach 0.088). Hypertension also did not reach statistical significance in relation to substatistical significance in relation to subcortical hypertensities ( cortical hypertensities (P P¼0.078). Other 0.078). Other cardiovascular risk factors did not correlate cardiovascular risk factors did not correlate with the severity of periventricular or subwith the severity of periventricular or subcortical white-matter hyperintensities. cortical white-matter hyperintensities.
DISCUSSION DISCUSSION
This is to our knowledge the first study This is to our knowledge the first study investigating the impact of brain whiteinvestigating the impact of brain whitematter hyperintensities on antidepressant matter hyperintensities on antidepressant treatment outcome in a non-geriatric study treatment outcome in a non-geriatric study sample. There are several important findsample. There are several important findings in this study. First, although we found ings in this study. First, although we found no correlation between global white-matter no correlation between global white-matter hyperintensity measures and clinical outhyperintensity measures and clinical outcome, subcortical hyperintensities in the come, subcortical hyperintensities in the left hemisphere were associated with poor left hemisphere were associated with poor outcome of antidepressant treatment. Preoutcome of antidepressant treatment. Previous studies in geriatric populations have vious studies in geriatric populations have described an association between subdescribed an association between subcortical and basal ganglia white-matter cortical and basal ganglia white-matter hyperintensity (and not periventricular hyperintensity (and not periventricular hyperintensity) and poor treatment outhyperintensity) and poor treatment outcome in major depressive disorder (Hickie come in major depressive disorder (Hickie et al et al, 1997; O'Brien , 1997; O'Brien et al et al, 1998; Simpson , 1998; Simpson et al et al, 1998; Steffens , 1998; Steffens et al et al, 2002) . However, , 2002) . However, to our knowledge there is no other to our knowledge there is no other report indicating a differential impact of report indicating a differential impact of left-hemisphere subcortical white-matter left-hemisphere subcortical white-matter hyperintensity on treatment outcome in hyperintensity on treatment outcome in major depressive disorder. Further studies major depressive disorder. Further studies will be needed to validate this association. will be needed to validate this association. Our finding is consistent with the report Our finding is consistent with the report of Greenwald of Greenwald et al et al (1998) , in which left (1998), in which left frontal subcortical white-matter lesions sigfrontal subcortical white-matter lesions significantly correlated with the diagnosis of nificantly correlated with the diagnosis of major depression. Also, previous reports major depression. Also, previous reports in post-stroke depression have indicated in post-stroke depression have indicated left-sided frontal lobe lesions as predictors left-sided frontal lobe lesions as predictors of severity of depression at 3 months and of severity of depression at 3 months and 6 months after the stroke (Robinson 6 months after the stroke (Robinson et et al al, 1985) ; left frontal localisation of stroke , 1985); left frontal localisation of stroke was not predictive of depression at longwas not predictive of depression at longterm follow-up (Shimoda & Robinson, term follow-up (Shimoda & Robinson, 1999) . However, this pattern would be con-1999). However, this pattern would be consistent with the results we are reporting sistent with the results we are reporting here, as only short-term, acute-phase treathere, as only short-term, acute-phase treatment outcomes were measured in our ment outcomes were measured in our study. study.
A second important finding in our A second important finding in our study was that brain white-matter hyperstudy was that brain white-matter hyperintensities were correlated with cardiointensities were correlated with cardiovascular risk factors in non-elderly people vascular risk factors in non-elderly people with major depressive disorder. It is therewith major depressive disorder. It is therefore possible that a large proportion of fore possible that a large proportion of brain hyperintensities in this younger popubrain hyperintensities in this younger population might be vascular in origin. Our lation might be vascular in origin. Our result is consistent with findings in nonresult is consistent with findings in nonpsychiatric populations, where brain psychiatric populations, where brain white-matter hyperintensities have been white-matter hyperintensities have been associated with age, cerebrovascular disassociated with age, cerebrovascular disease (Awad ease (Awad et al et al, 1986; Fazekas , 1986; Fazekas et al et al, , 1993 ) and cardiovascular risk factors such 1993) and cardiovascular risk factors such as smoking, arterial hypertension and inas smoking, arterial hypertension and increased serum cholesterol (Breteler creased serum cholesterol (Breteler et al et al, , 1994; Liao 1994; Liao et al et al, 1997; Schmidt , 1997; Schmidt et al et al, , 1997) . In neuropathological analyses of 1997). In neuropathological analyses of brains from people with major depressive brains from people with major depressive disorder, subcortical white-matter hyperindisorder, subcortical white-matter hyperintensities were all ischaemic (Thomas tensities were all ischaemic (Thomas et al et al, , 2002) , whereas periventricular lesions had 2002), whereas periventricular lesions had multiple causes (Thomas multiple causes (Thomas et al et al, 2003) . , 2003). One possible interpretation of our reOne possible interpretation of our results is that cardiovascular risk factors corsults is that cardiovascular risk factors correlate with a higher severity of subcortical relate with a higher severity of subcortical white-matter lesions, which in turn correwhite-matter lesions, which in turn correlates with poor treatment outcome in lates with poor treatment outcome in depression. This interpretation would be depression. This interpretation would be consistent with the 'vascular depression' consistent with the 'vascular depression' model. However, the vascular depression model. However, the vascular depression hypothesis would call for a higher prevahypothesis would call for a higher prevalence of hyperintensities in patients with delence of hyperintensities in patients with depression compared with normal controls, pression compared with normal controls, which was not found in our study. Also, which was not found in our study. Also, the vascular depression model would sugthe vascular depression model would suggest a relationship between global measures gest a relationship between global measures of brain white-matter hyperintensities and of brain white-matter hyperintensities and treatment outcome, whereas in our sample treatment outcome, whereas in our sample only subcortical hyperintensities in the left only subcortical hyperintensities in the left hemisphere (and no other hyperintensities) hemisphere (and no other hyperintensities) were associated with poor response to were associated with poor response to antidepressant treatment. Other factors, antidepressant treatment. Other factors, such as interruption by white-matter such as interruption by white-matter hyperintensities of specific white-matter hyperintensities of specific white-matter tracts involved in mood regulation, may tracts involved in mood regulation, may explain our observed result of a selective explain our observed result of a selective impact of left-hemisphere subcortical impact of left-hemisphere subcortical hyperintensi hyperintensities on treatment outcome. ties on treatment outcome. Other predictors Other predictors of treatment outcome, of treatment outcome, which may mediate the relationship which may mediate the relationship between white-matter hyperintensity and between white-matter hyperintensity and treatment response, might have been missed treatment response, might have been missed in this study owing to the relatively small in this study owing to the relatively small sample size. sample size.
There are several limitations to our There are several limitations to our study. First, we used a whole-brain rating study. First, we used a whole-brain rating scale (Fazekas scale (Fazekas et al et al, 1987) to assess the , 1987) to assess the severity of brain white-matter hyperseverity of brain white-matter hyperintensities. Although most studies on this intensities. Although most studies on this topic reported using modified versions of topic reported using modified versions of the Fazekas scale, this method does not the Fazekas scale, this method does not allow for a detailed morphological and allow for a detailed morphological and volumetric analysis of brain white-matter volumetric analysis of brain white-matter hyperintensity (Taylor hyperintensity (Taylor et al et al, 2003) . We , 2003). We did not measure hyperintensity localisadid not measure hyperintensity localisations such as basal ganglia, which have tions such as basal ganglia, which have been previously described as associated been previously described as associated with treatment outcome in major depreswith treatment outcome in major depressive disorder (Simpson sive disorder (Simpson et al et al, 1998) . Second, , 1998) . Second, we measured only total cholesterol and not we measured only total cholesterol and not fractions of cholesterol, therefore our refractions of cholesterol, therefore our results may not reflect the full impact of this sults may not reflect the full impact of this cardiovascular risk factor. Third, we have cardiovascular risk factor. Third, we have a potential sampling bias, as we enrolled a potential sampling bias, as we enrolled participants from two antidepressant trials participants from two antidepressant trials with specific inclusion and exclusion with specific inclusion and exclusion criteria and with different treatments criteria and with different treatments (fluoxetine and nortriptyline); as a result, (fluoxetine and nortriptyline); as a result, this sample may not directly reflect the this sample may not directly reflect the typical out-patient population. typical out-patient population. Subcortical white-matter hyperintensities in the left hemisphere were associated with poor response to antidepressant treatment in major depressive disorder, but we with poor response to antidepressant treatment in major depressive disorder, but we found no correlation between global white-matter hyperintensity measures and found no correlation between global white-matter hyperintensity measures and clinical outcome. clinical outcome.
& & In younger people with major depressive disorder, the presence of such In younger people with major depressive disorder, the presence of such hyperintensities was associated with cardiovascular risk factors (hypertension and hyperintensities was associated with cardiovascular risk factors (hypertension and age) and with the total cardiovascular risk score. age) and with the total cardiovascular risk score.
& & We found no difference in the prevalence or distribution of white-matter We found no difference in the prevalence or distribution of white-matter hyperintensities between healthy volunteers and two groups of younger people with hyperintensities between healthy volunteers and two groups of younger people with depression (treatment-resistant and non-treatment-resistant). depression (treatment-resistant and non-treatment-resistant). We enrolled participants from two separate antidepressant trials, using different treatments (fluoxetine and nortriptyline). treatments (fluoxetine and nortriptyline).
LIMITATIONS LIMITATIONS
